Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-29 @ 1:48 PM
Study NCT ID:
NCT01643603
Status:
TERMINATED
Last Update Posted:
2020-12-17
First Post:
2012-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
None
Primary Completion Date:
2018-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-30
First Submit QC Date:
None
Study First Post Date:
2012-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-14
Last Update Post Date:
2020-12-17
Last Update Post Date Type:
ACTUAL